Declared management methods used by the Polish psychiatrists among a group of people with a high risk syndrome of psychosis development: results of the national Polish questionnaire
Journal Title: Psychiatria Polska - Year 2011, Vol 45, Issue 3
Abstract
Summary Aim. The aim of the study was to assess the declared management methods used byPolish psychiatrists among a group of people at high risk of psychosis development. Method. Management methods used among two kinds of UHR persons, i.e. (A) attenuated or brief, limited psychotic symptoms group and (B) state and trait risk factors group, were assessed during nationwide psychiatric conferences held in 2009, which gathered Polish psychiatrists practicing throughout the whole country. Results. (A) For those experiencing attenuated or brief, limited psychotic symptoms (APS or BLIPS), the vast majority of respondents (88%) declared using pharmacological intervention. Moreover, all doctors choosing pharmacotherapy declared using antipsychotic drugs (AP). Second generation antipsychotics (SGA) (84%), i.e. risperidone (48%) and olanzapine (32%) were medications to be selected as the first choice. Most doctors declared that they use medium doses of AP (46%) for minimum 6–12 months (31%). (B) Among the group of people with state and trait risk factors, the vast majority of respondents (81%) also declared using AP: mostly SGA (75%) and typical AP (20%). Medications used as the first choice in this group were also mostly risperidone and olanzapine (44% and 28% respectively). 65% of the doctors declared using low doses of antipsychotics for the minimum of 6-12 months (39%). Conclusions. A high percentage of Polish psychiatrists state that they use pharmacological intervention in persons at high risk of developing psychosis. Preferred medications are mainly SGA (risperidone and olanzapine), prescribed in medium and low doses for a minimum of 6-12 months.
Authors and Affiliations
Tomasz Pawełczyk, Agnieszka Pawełczyk, Jolanta Rabe-Jabłońska
Keywords
Related Articles
- EP ID EP160754
- DOI -
- Views 97
- Downloads 0
Opinie lekarzy dotyczące perazyny w leczeniu zaburzeń psychicznych – wyniki badania metodą delficką
Cel badań. Współcześnie stosowanie leków przeciwpsychotycznych pierwszej generacji (LPIG) jest znacznie ograniczone a jednocześnie nie u każdego pacjenta można zastosować lek drugiej generacji (LPIIG). Dlatego istotne zn...
Links between duration and severity of anxiety and depressive symptoms with defence mechanisms, coherence and family functioning in patients suffering from severe panic disorder
Background. Panic disorder often has a chronic course and is comorbid with depression. Many different psychological factors may have impact on both chronicity and comorbidity. Aim. The purpose of the study was to access...
Perazine in the treatment of psychotic disorders – research review
The author reviewed the relatively poor literature on the topic and its key clinical trial reports on perazine, a classical antipsychotic most frequently prescribed in Poland for psychoses, especially for schizophrenia....
Maurycy Urstein: zapomniany polski współtwórca niemieckiej psychiatrii
Polski psychiatra Maurycy Urstein (1872–1940) jest dzisiaj niemal zupełnie zapomniany. Nie wymienia się go wśród twórców polskiej psychiatrii, co częściowo może usprawiedliwiać fakt, że był głównie autorem niemieckojęzyc...
Classification of persons attempting suicide. A review of cluster analysis research
Aim: Review of conclusions from cluster analysis research on suicide risk factors published after the year 1993. Methods: Search and analysis of cluster analysis research papers on suicidal behaviour. Results : Following...